| BC | bladder cancer |
| CI | confidence interval |
| ECOG | Eastern Cooperative Oncology Group |
| FFPE | formalin-fixed and paraffin-embedded |
| GC | gemcitabine + cisplatin |
| HR | hazard ratio |
| IHC | immunohistochemistry |
| MIBC | muscle-invasive bladder cancer |
| MMP-7 | matrix metalloproteinase-7 |
| NMIBC | non-muscle-invasive bladder cancer |
| OS | overall survival |
| PFS | progression-free survival |
| SDC1 | syndecan-1 |
| MVAC | methotrexate + vinblastine plus + doxorubicine + cisplatin |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.